Literature DB >> 15331060

Epidemiology of nonalcoholic fatty liver.

Constance E Ruhl1, James E Everhart.   

Abstract

Nonalcoholic fatty liver (NAFL) is increasingly recognized as an important and common public health problem that can lead to cirrhosis and hepatic failure. Because it is often asymptomatic,many people may not know that they have it. NAFL is closely linked to obesity, which in the United States and other developed countries is becoming more common. Consequently, the proportion of the population affected by NAFL will likely increase. Despite the growing importance of this condition, knowledge of the epidemiology of NAFL is limited by the lack of an accurate,noninvasive measure for use in screening of the general population. This article reviews information available from studies with relatively unselected samples with regard to prevalence, demographics,and risk factors for NAFL.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331060     DOI: 10.1016/j.cld.2004.04.008

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  49 in total

1.  Non-alcoholic fatty liver disease: is iron relevant?

Authors:  Julia O'Brien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2011-08-12       Impact factor: 6.047

Review 2.  Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.

Authors:  Paul D Berk
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

Review 3.  Hepatic triacylglycerol accumulation and insulin resistance.

Authors:  Cynthia A Nagle; Eric L Klett; Rosalind A Coleman
Journal:  J Lipid Res       Date:  2008-11-06       Impact factor: 5.922

4.  Impact of weight-loss surgery and diabetes status on serum ALT levels.

Authors:  Dimitrios Xourafas; Ali Ardestani; Stanley W Ashley; Ali Tavakkoli
Journal:  Obes Surg       Date:  2012-10       Impact factor: 4.129

Review 5.  Psychological and psychiatric aspects of treatment of obesity and nonalcoholic fatty liver disease.

Authors:  Karen E Stewart; James L Levenson
Journal:  Clin Liver Dis       Date:  2012-06-26       Impact factor: 6.126

6.  Assessment of liver steatosis in chicken by using acoustic radiation force impulse imaging: preliminary results.

Authors:  Florentina Guzmán Aroca; Ignacio Ayala; Laura Serrano; Juan D Berná-Serna; María T Castell; Bartolomé García-Pérez; Manuel Reus
Journal:  Eur Radiol       Date:  2010-05-07       Impact factor: 5.315

7.  Risk factors for liver disease and associated knowledge and practices among Mexican adults in the US and Mexico.

Authors:  Yvonne N Flores; Cathy M Lang; Jorge Salmerón; Roshan Bastani
Journal:  J Community Health       Date:  2012-04

8.  PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver.

Authors:  Mohamed A Abdelmegeed; Seong-Ho Yoo; Lauren E Henderson; Frank J Gonzalez; Kimberley J Woodcroft; Byoung-Joon Song
Journal:  J Nutr       Date:  2011-02-23       Impact factor: 4.798

9.  Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004.

Authors:  Yvonne N Flores; Hal F Yee; Mei Leng; José J Escarce; Roshan Bastani; Jorge Salmerón; Leo S Morales
Journal:  Am J Gastroenterol       Date:  2008-07-30       Impact factor: 10.864

10.  High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo.

Authors:  Sudheer K Mantena; Denty Paul Vaughn; Kelly K Andringa; Heather B Eccleston; Adrienne L King; Gary A Abrams; Jeannette E Doeller; David W Kraus; Victor M Darley-Usmar; Shannon M Bailey
Journal:  Biochem J       Date:  2009-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.